Oncostatin M is a novel biomarker for coronary artery disease – A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus

by Shohei Ikeda, Koichi Sato, Morihiko Takeda, Keita Miki, Kentaro Aizawa, Tsuyoshi Takada, Koji Fukuda, Nobuyuki Shiba
Published 2021-08-01

Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.

by Kazuki Noda, Sota Nakajima, Shigeo Godo, Hiroki Saito, Shohei Ikeda, Toru Shimizu, Budbazar Enkhjargal, Yoshihiro Fukumoto, Sohei Tsukita, Tetsuya Yamada, Hideki Katagiri, Hiroaki Shimokawa
Published 2014-01-01

Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart

by Shohei Ikeda, MD, PhD, Risa Mukai, MD, PhD, Wataru Mizushima, MD, PhD, Peiyong Zhai, MD, PhD, Shin-ichi Oka, PhD, Michinari Nakamura, MD, PhD, Dominic P. Del Re, PhD, Sebastiano Sciarretta, MD, PhD, Chiao-Po Hsu, MD, PhD, Hiroaki Shimokawa, MD, PhD, Junichi Sadoshima, MD, PhD
Published 2019-09-01